List of Studies ( Metabolite:Ile-Asp-Ser)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST002024 | AN003294 | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001384 | AN002309 | Plasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry season | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001299 | AN002163 | Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran | Cecum | Mouse | Pennsylvania State University | LC-MS | |
| ST001008 | AN001650 | Multi-Platform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity (part II) | Cecum | Mouse | Pennsylvania State University | LC-MS |
